Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
Clicks: 256
ID: 5846
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
71.8
/100
256 views
205 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA projectReference Key |
paola2019lipidinfection
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Paola Bagella;Nicola Squillace;Elena Ricci;Roberto Gulminetti;Giuseppe Vittorio De Socio;Lucia Taramasso;Giovanni Pellicanò;Barbara Menzaghi;Benedetto Maurizio Celesia;Chiara Dentone;Giancarlo Orofino;Paolo Bonfanti;Giordano Madeddu and |
Journal | Infection and drug resistance |
Year | 2019 |
DOI | 10.2147/IDR.S203813 |
URL | |
Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.